Beijing Novacon Pharmaceutical Technology

Beijing Novacon Pharmaceutical Technology is a leading Chinese Contract Research Organization (CRO) specializing in pharmaceutical research and development with a focus on drug formulation and CMC (Chemistry, Manufacturing, and Controls). Founded in 2013, the company provides comprehensive services ranging from non-clinical research and pharmaceutical technology development to clinical trial management and regulatory affairs. Novacon is particularly recognized for its expertise in complex formulations, including sustained-release, controlled-release, and injectable technologies, supporting both generic drug consistency evaluations and the development of improved new drugs.